Search Results - infectious+disease

6 Results Sort By:
Dual stimuli-responsive silver loaded nanoparticles eliminate bacterial biofilms
Dual stimuli-responsive silver loaded nanoparticles eliminate bacterial biofilms Overview Bacterial biofilms are complex, 3D bacterial communities that are embedded in a self-produced matrix of extracellular polymeric substances. Although biofilms are a common occurrence in human infections, they are extremely difficult to eradicate as their matrix...
Published: 3/5/2025   |   Inventor(s): Anita Shukla, Yingying Wang, Zhaowei Jiang
Keywords(s):  
Category(s): Nanotechnology, Infectious Disease, Drug Delivery
Covid Prevention and Treatment Using an Integrin Inhibitor
Overview Although several highly effective vaccines against COVID-19 have been developed, the disease remains a threat to public health. We have invented a method of preventing or treating COVID-19 through administration of an integrin inhibitor such as GLPG-0187. Market Opportunity Although several highly effective vaccines against COVID-19 have...
Published: 3/17/2025   |   Inventor(s): Wafik El-Deiry, Kelsey Huntington, Lindsey Carlsen, Olin Liang, Matthias Piesche
Keywords(s):  
Category(s): Therapeutics, Infectious Disease
Ultra-Specific and Ultra-Sensitive Platform for Highly-Reliable and High-Precision SARS-CoV-2 Detection
Background:The technology described is based on the use of two unique sets of detection molecules that are specific to a protein contained in the viral shell of SARS CoV-2 and Covid-19 that is unique from other known common cold causing coronaviruses. The proposed system uses two different fluorescent probes for two different regions of the viral shell...
Published: 10/26/2023   |   Inventor(s): Rodrigo Fernandez-Valdivia
Keywords(s): Coronavirus, COVID-19, Diagnostic, Virus
Category(s): Diagnostic, Biomedical, Medical, Diseases, Infectious disease
SALT-FORMULATED VALPROATE AS A TOPICAL ANTI-FUNGAL TREATMENT
In 2018, the global antifungal drugs market size was valued at USD 11.6 billion. Generally speaking, 54.3% of sales are prescription and 45.7% is over-the counter OTC/Alternative. It is anticipated that the OTC/Alternative portion of the global antifungal market will continue to grow. Science is indicating that both the number of systemic infections...
Published: 7/25/2025   |   Inventor(s): Miriam Greenberg, Rania Deranieh
Keywords(s):  
Category(s): Diseases, Infectious disease, Life Science, Small molecule, Pharmaceuticals
Vaginal microbiome snapshot (VMS)
Vaginal Microbiome Sanpshot; a Method for Diagnosing Bacterial Vaginosis and Other Vaginal Disorders WSU Tech#: 13-1141 Technology Summary: Bacterial vaginosis (BV) is a disease of the vagina caused by an imbalance of naturally occurring bacterial flora and is often confused with yeast infection (candidiasis) or infection with Trichomonas vaginalis...
Published: 10/27/2020   |   Inventor(s): Robert Akins, Jack Sobel
Keywords(s):  
Category(s): Assays, Biomedical, Diagnostic, Diagnostics, Infectious disease
Antibacterial activity of natural compounds and their synthetic analogue: A potential new antibiotic with potent activity against multiple drug resistant bacterial pathogens
Our researchers have developed novel compounds that are potential new anti-infective therapeutics useful for treatment against the deadly bacteria MRSA (methicillin-resistant Staphylococcus aureus), VRE (vancomycin-resistant Enterococcus faecium), and several other well-known common infectious agents.Background & Unmet Need:Before antibiotics became...
Published: 8/9/2022   |   Inventor(s): Hossein Salimnia, Fazlul Sarkar, Subhash Padhye, Bernhard Biersack
Keywords(s): Analog or Analogue, Antibiotics, Anti-infective, Anti-microbial, Disease
Category(s): Biologicals, Diseases, Infectious disease, Life Science, Therapeutics